An automated system using spatial oversampling for optical mapping in murine atria. Development and validation with monophasic and transmembrane action potentials

Progress in Biophysics and Molecular Biology

Volumn 115, Issue 2-3, 2014, Pages 340-348

  Yu, Ting Yue ^a   Syeda, Fahima ^a   Holmes, Andrew P ^a   Osborne, Benjamin ^a   Dehghani, Hamid ^a   Brain, Keith L ^a   Kirchhof, Paulus ^a   Fabritz, Larissa ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Atrial action potential duration; Atrial fibrillation; Conduction velocity; Isolated atrium; Murine model; Optical mapping

Indexed keywords

ACTION POTENTIAL; ANIMAL; AUTOMATED PATTERN RECOGNITION; DEVICES; HEART MUSCLE CONDUCTION SYSTEM; MOUSE; NERVE CONDUCTION; PHOTOGRAPHY; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING; VOLTAGE SENSITIVE DYE IMAGING;

ACTION POTENTIALS; ANIMALS; HEART CONDUCTION SYSTEM; MICE; NEURAL CONDUCTION; PATTERN RECOGNITION, AUTOMATED; PHOTOGRAPHY; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING, COMPUTER-ASSISTED; VOLTAGE-SENSITIVE DYE IMAGING;

EID: 84908609571     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2014.07.012     Document Type: Article

References (53)

1. Arora R., Verheule S., Scott L., Navarrete A., Katari V., Wilson E., et al. Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation 2003, 107:1816-1821. 10.1161/01.Cir.0000058461.86339.7e.
2. Bachtel A.D., Gray R.A., Stohlman J.M., Bourgeois E.B., Pollard A.E., Rogers J.M. Anovel approach to dual excitation ratiometric optical mapping of cardiac action potentials with di-4-ANEPPS using pulsed LED excitation. IEEE Trans. Biomed. Eng. 2011, 58:2120-2126. 10.1109/TBME.2011.2148719.
3. Baker L.C., London B., Choi B.-R., Koren G., Salama G. Enhanced dispersion of repolarization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ. Res. 2000, 86:396-407. 10.1161/01.RES.86.4.396.
4. Benes J., Ammirabile G., Sankova B., Campione M., Krejci E., Kvasilova A., et al. The role of connexin40 in developing atrial conduction. Fed. Eur. Biochem. Sci. Lett. 2014, 588:1465-1469. 10.1016/j.febslet.2014.01.032.
5. Benjamin E.J., Rice K.M., Arking D.E., Pfeufer A., van Noord C., Smith A.V., et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat. Genet. 2009, 41:879-881. 10.1038/ng.416.
6. Bezzina C.R., Barc J., Mizusawa Y., Remme C.A., Gourraud J.-B., Simonet F., et al. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat. Genet. 2013, 45:1044-1049. 10.1038/ng.2712.
7. Blana A., Kaese S., Fortmuller L., Laakmann S., Damke D., van Bragt K., et al. Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability. Heart Rhythm 2010, 7:1862-1869. 10.1016/j.hrthm.2010.08.016.
8. Brunner M., Kodirov S. Invivo gene transfer of Kv1. 5 normalizes action potential duration and shortens QT interval in mice with long QT phenotype. Am. J. Physiol. Heart Circ. Physiol. 2003, 194-203. 02115.
9. Camm A.J., Al-Khatib S.M., Calkins H., Halperin J.L., Kirchhof P., Lip G.Y.H., et al. Aproposal for new clinical concepts in the management of atrial fibrillation. Am. Heart J. 2012, 164:292-302.e1. 10.1016/j.ahj.2012.05.017.
10. Camm A.J., Lip G.Y.H., De Caterina R., Savelieva I., Atar D., Hohnloser S.H., et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur. Heart J. 2012, 33:2719-2747. 10.1093/eurheartj/ehs253.
11. Di Diego J.M., Sicouri S., Myles R.C., Burton F.L., Smith G.L., Antzelevitch C. Optical and electrical recordings from isolated coronary-perfused ventricular wedge preparations. J.Mol. Cell. Cardiol. 2013, 54:53-64. 10.1016/j.yjmcc.2012.10.017.
12. Dou Y., Arlock P., Arner A. Blebbistatin specifically inhibits actin-myosin interaction in mouse cardiac muscle. Am. J. Physiol. Cell Physiol. 2007, 1148-1153. 10.1152/ajpcell.00551.2006.
13. Eckstein J., Zeemering S., Linz D., Maesen B., Verheule S., van Hunnik A., et al. Transmural conduction is the predominant mechanism of breakthrough during atrial fibrillation: evidence from simultaneous endo-epicardial high-density activation mapping. Circ. Arrhythm. Electrophysiol. 2013, 6:334-341. 10.1161/CIRCEP.113.000342.
14. Efimov I., Fahy G. High resolution fluorescent imaging does not reveal a distinct atrioventricular nodal anterior input channel (fast pathway) in the rabbit heart during sinus rhythm. J.Cardiovasc. Electrophysiol. 1997, 8:295-306.
15. Efimov I.R., Huang D.T., Rendt J.M., Salama G. Optical mapping of repolarization and refractoriness from intact hearts. Circulation 1994, 90:1469-1480.
16. Ehrenberg B., Farkas D.L., Fluhler E.N., Lojewska Z., Loew L.M. Membrane potential induced by external electric field pulses can be followed with a potentiometric dye. Biophys. J. 1987, 51:833-837. 10.1016/S0006-3495(87)83410-0.
17. Ellinor P.T., Lunetta K.L., Albert C.M., Glazer N.L., Ritchie M.D., Smith A.V., et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat. Genet. 2012, 44:670-675. 10.1038/ng.2261.
18. Fabritz L., Damke D., Emmerich M., Kaufmann S.G., Theis K., Blana A., et al. Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3. Cardiovasc. Res. 2010, 87:60-72. 10.1093/cvr/cvq029.
19. Fabritz L., Fortmuller L., Yu T.Y., Paul M., Kirchhof P. Can preload-reducing therapy prevent disease progression in arrhythmogenic right ventricular cardiomyopathy? Experimental evidence and concept for a clinical trial. Prog. Biophys. Mol. Biol. 2012, 110:340-346. 10.1016/j.pbiomolbio.2012.08.010.
20. Fabritz L., Hoogendijk M.G., Scicluna B.P., van Amersfoorth S.C., Fortmueller L., Wolf S., et al. Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice. J.Am. Coll. Cardiol. 2011, 57:740-750. 10.1016/j.jacc.2010.09.046.
21. Faggioni M., Savio-Galimberti E., Venkataraman R., Hwang H.S., Kannankeril P.J., Darbar D., et al. Suppression of spontaneous ca elevations prevents atrial fibrillation in calsequestrin 2-null hearts. Circ. Arrhythm. Electrophysiol. 2014, 7:313-320. 10.1161/CIRCEP.113.000994.
22. Fedorov V.V., Lozinsky I.T., Sosunov E.A., Anyukhovsky E.P., Rosen M.R., Balke C.W., et al. Application of blebbistatin as an excitation-contraction uncoupler for electrophysiologic study of rat and rabbit hearts. Heart Rhythm 2007, 4:619-626. 10.1016/j.hrthm.2006.12.047.
23. Glukhov A., Flagg T., Fedorov V. Differential K ATP channel pharmacology in intact mouse heart. J.Mol. Cell. Cardiol. 2010, 48:152-160. 10.1016/j.yjmcc.2009.08.026.
24. Gudbjartsson D.F., Arnar D.O., Helgadottir A., Gretarsdottir S., Holm H., Sigurdsson A., et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007, 448:353-357. 10.1038/nature06007.
25. Jou C.J., Spitzer K.W., Tristani-Firouzi M. Blebbistatin effectively uncouples the excitation-contraction process in zebrafish embryonic heart. Cell. Physiol. Biochem. 2010, 25:419-424. 10.1159/000303046.
26. Kirchhof P., Breithardt G., Aliot E., Al Khatib S., Apostolakis S., Auricchio A., et al. Personalized management of atrial fibrillation: proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace 2013, 15:1540-1556. 10.1093/europace/eut232.
27. Kirchhof P., Kahr P., Kaese S. PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression. Circ. Cardiovasc. Genet. 2011, 10.1161/CIRCGENETICS.110.958058.
28. Kirchhof P., Marijon E., Fabritz L., Li N., Wang W., Wang T., et al. Overexpression of cAMP-response element modulator causes abnormal growth and development of the atrial myocardium resulting in a substrate for sustained atrial fibrillation in mice. Int. J. Cardiol. 2011, 10.1016/j.ijcard.2011.10.057.
29. Knollmann B.C., Katchman A.N., Franz M.R. Monophasic action potential recordings from intact mouse heart: validation, regional heterogeneity, and relation to refractoriness. J.Cardiovasc. Electrophysiol. 2001, 12:1286-1294.
30. Kohl P., Hunter P., Noble D. Stretch-induced changes in heart rate and rhythm: clinical observations, experiments and mathematical models. Prog. Biophys. Mol. Biol. 1999, 71:91-138. 10.1016/S0079-6107(98)00038-8.
31. Laughner J.I., Ng F.S., Sulkin M.S., Arthur R.M., Efimov I.R. Processing and analysis of cardiac optical mapping data obtained with potentiometric dyes. Am. J. Physiol. Heart Circ. Physiol. 2012, 303:H753-H765. 10.1152/ajpheart.00404.2012.
32. Lee P., Bollensdorff C., Quinn T.A., Wuskell J.P., Loew L.M., Kohl P. Single-sensor system for spatially resolved, continuous, and multiparametric optical mapping of cardiac tissue. Heart Rhythm 2011, 8:1482-1491. 10.1016/j.hrthm.2011.03.061.
33. Lee P., Taghavi F., Yan P., Ewart P., Ashley E.A., Loew L.M., et al. In situ optical mapping of voltage and calcium in the heart. PLoS One 2012, 7:e42562. 10.1371/journal.pone.0042562.
34. Lee P., Yan P., Ewart P., Kohl P., Loew L.M., Bollensdorff C. Simultaneous measurement and modulation of multiple physiological parameters in the isolated heart using optical techniques. Pflugers Arch. 2012, 464:403-414. 10.1007/s00424-012-1135-6.
35. Lemoine M.D., Duverger J.E., Naud P., Chartier D., Qi X.Y., Comtois P., et al. Arrhythmogenic left atrial cellular electrophysiology in a murine genetic long QT syndrome model. Cardiovasc. Res. 2011, 92:67-74. 10.1093/cvr/cvr166.
36. Loew L.M. Potentiometric dyes: imagingelectrical activity of cell membranes. Pure Appl. Chem. 1996, 68:1405-1409. 10.1351/pac199668071405.
37. Mandapati R., Skanes A., Chen J., Berenfeld O., Jalife J. Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation 2000, 101:194-199. 10.1161/01.CIR.101.2.194.
38. Park J., Werley C.A., Venkatachalam V., Kralj J.M., Dib-Hajj S.D., Waxman S.G., et al. Screening fluorescent voltage indicators with spontaneously spiking HEK cells. PLoS One 2013, 8:e85221. 10.1371/journal.pone.0085221.
39. Riley G., Syeda F., Kirchhof P., Fabritz L. An introduction to murine models of atrial fibrillation. Front. Physiol. 2012, 3:296. 10.3389/fphys.2012.00296.
40. Rohr S., Salzberg B.M. Multiple site optical recording of transmembrane voltage (MSORTV) in patterned growth heart cell cultures: assessing electrical behavior, with microsecond resolution, on a cellular and subcellular scale. Biophys. J. 1994, 67:1301-1315. 10.1016/S0006-3495(94)80602-2.
41. Salama G., Lombardi R., Elson J. Maps of optical action potentials and NADH fluorescence in intact working hearts. Am. J. Physiol. 1987, 252:H384-H394.
42. Salzberg B.M., Davila H.V., Cohen L.B. Optical recording of impulses in individual neurones of an invertebrate Central nervous system. Nature 1973, 246:508-509. 10.1038/246508a0.
43. Savitzky A., Golay M.J.E. Smoothing and differentiation of data by simplified least squares procedures. Anal. Chem. 1964, 36:1627-1639. 10.1021/ac60214a047.
44. Schotten U., Verheule S., Kirchhof P., Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol. Rev. 2011, 91:265-325. 10.1152/physrev.00031.2009.
45. Seo K., Inagaki M., Hidaka I., Fukano H., Sugimachi M., Hisada T., Nishimura S., Sugiura S. Relevance of cardiomyocyte mechano-electric coupling to stretch-induced arrhythmias: Optical voltage/calcium measurement in mechanically stimulated cells, tissues and organs. Prog. Bio. Mol. Biol. 2014, 115(2-3):129-139. 10.1016/j.pbiomolbio.2014.07.008.
46. Verheule S., Sato T., Everett T., Engle S.K., Otten D., Rubart-von der Lohe M., et al. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ. Res. 2004, 94:1458-1465. 10.1161/01.RES.0000129579.59664.9d.
47. Verheule S., Tuyls E. Loss of continuity in the thin epicardial layer because of endomysial fibrosis increases the complexity of atrial fibrillatory conduction. Circ. Arrhythm. Electrophysiol. 2013, 202-211. 10.1161/CIRCEP.112.975144.
48. Verheule S., Eckstein J., Linz D., Maesen B., Bidar E., Gharaviri A., Schotten U. Role of endo-epicardial dissociation of electrical activity and transmural conduction in the development of persistent atrial fibrillation. Prog. Bio. Mol. Biol. 2014, 115(2-3):173-185. 10.1016/j.pbiomolbio.2014.07.007.
49. Wakili R., Voigt N., Kääb S., Dobrev D., Nattel S. Recent advances in the molecular pathophysiology of atrial fibrillation. J.Clin. Invest. 2011, 121:2955-2968. 10.1172/JCI46315.
50. Waldeyer C., Fabritz L., Fortmueller L., Gerss J., Damke D., Blana A., et al. Regional, age-dependent, and genotype-dependent differences in ventricular action potential duration and activation time in 410 Langendorff-perfused mouse hearts. Basic Res. Cardiol. 2009, 104:523-533. 10.1007/s00395-009-0019-1.
51. Wang J., Klysik E., Sood S. Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification. Proc. Natl. Acad. Sci. 2010, 1-6. 10.1073/pnas.0912585107.
52. Wu J., Biermann M., Rubart M., Zipes D.P. Cytochalasin D as excitation-contraction uncoupler for optically mapping action potentials in wedges of ventricular myocardium. J.Cardiovasc. Electrophysiol. 1998, 9:1336-1347.
53. Wu J., Olgin J., Miller J., Zipes D. Mechanisms underlying the reentrant circuit of atrioventricular nodal reentrant tachycardia in isolated canine atrioventricular nodal preparation using optical mapping. Circ. Res. 2001, 1189-1195.